Roche/Sanofi on joint multinational clinical studies for cancer drugs.

Published: 2006-04-07 06:57:00

Updated: 2006-04-07 06:57:00

The phase III clinical study called CLASSIC (Capecitabine and OxaLiplatin Adjuvant Study in Stomach Cancer) for an adjuvant cancer therapy after the stomach surgical operation may be jointly conducted by Roche Korea and Sanofi-Aventis Korea to assess the effects of Xeloda (Capecitabine) and Eloxa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK